Business Wire

BENTALLGREENOAK/BULK

22.12.2020 07:32:07 CET | Business Wire | Press release

Share
Bulk Infrastructure Announces Strategic Partnership with BentallGreenOak, Raising NOK 1.5 Billion/EUR 140 Million to Support the Future Growth of Sustainable Digital Infrastructure

Bulk Infrastructure Holding AS, a Nordic data center, fiber network developer and operator, and logistics real estate developer, announced a new partnership with BentallGreenOak (BGO), a global real estate investment manager, as a strategic partner and investor. BentallGreenOak has committed NOK 1.5 billion (approximately €140 million) to support the future growth of Bulk Infrastructure’s core lines of business.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201221005784/en/

BentallGreenOak joins main shareholders, Bulk Industrier and Geveran, in securing capital for the company’s future growth, with a series of capital injections from BGO and existing shareholders that will take place from January, 2021. John Carrafiell, Senior Managing Partner and Co-founder of BentallGreenOak, will join Bulk Infrastructure’s Board of Directors, and founder, Peder Nærbø, and his company Bulk Industrier, will continue to work actively within the company and remain the lead investor and Chairman of the Board. Bulk Infrastructure’s capital-intensive investments are advancing scalable, sustainable solutions in infrastructure and real estate that are poised to make long-lasting, positive impacts to the environment.

Bulk Infrastructure, in partnership with BentallGreenOak, expects to invest in the continuing development of its N01 Data Center Campus in south Norway. At 3 million sqm (740 acres) and up to 1 GigaWatt of IT power, N01 Campus has the ambition to become the world’s largest data center campus powered by 100% renewable energy. This data center campus provides integral access to Bulk Infrastructure’s recently completed Havfrue fiber cable, the first trans-Atlantic subsea cable system into the Nordics in almost two decades, providing unparalleled connectivity between Northern Europe and the U.S. Bulk Infrastructure’s planned new cable project, called Leif Erikson, between Norway and Atlantic Canada will further improve connectivity, and build on BGO’s strong position and history in the Canadian market.

“We want to unlock the potential the Nordics and renewable energy has to offer in sustainable digital infrastructure,” says Peder Nærbø, founder of Bulk Infrastructure. “With a top tier international investor like BentallGreenOak in our company, we will enable faster growth and better scale for our opportunities,” the founder continues. “This provides us with a great platform for reaching our vision of bringing sustainable infrastructure to a global audience, and to serve the biggest and most demanding customers out there,” says Nærbø.

“This partnership with Bulk Infrastructure is a perfect match for BGO,” says Senior Managing Partner and Co-founder of BentallGreenOak, John Carrafiell. “BGO has been focused on the European logistics market since 2013, and, similar to Bulk's own evolution, considers data centers to be a natural extension of the firm’s real estate investment strategy. Bulk Infrastructure's commitment to building on the Nordic region's natural advantages to deliver strong economic and environmental performance in real estate and infrastructure, is well-aligned with BGO's own investment priorities. We are pleased to be developing exciting new pathways, on behalf of our investors, that deliver performance-driven investment opportunities that also benefit the local economy and maintain a focus on environmental sustainability.”

“This partnership provides us with a solid financial platform as Bulk Infrastructure is opportunity rich in all three business areas. As an example, we see opportunities for major capacity add in our three existing Data Center campuses as well as in other Nordic destinations. Bulk Infrastructure’s combination of reliable and cost-effective access to 100% green power from renewable sources, cold climate, stable business environment, and well-positioned fiber optic network, is uniquely situated to attract a significant share of the rapidly growing European and global data center market,” says Bulk Infrastructure CEO, Jon Gravråk.

Arctic Securities, Pareto Securities, PwC and Schjødt served as advisors to Bulk Infrastructure on the partnership and BentallGreenOak were advised by Wiersholm and EY.

About Bulk Infrastructure

Bulk Infrastructure is a leading provider of sustainable digital infrastructure in the Nordics. We are an industrial investor, developer and operator of industrial real estate, data centers and dark fiber networks. We believe in the value creation opportunity of enabling our digital society to be fully sustainable. Our ambition is to be the go-to player for anyone that wants to leverage the Nordics for data processing requirements of the future. We have a track record of delivering high quality and cost-effective customer solutions with short time to market. Hence our vision: Racing to bring sustainable infrastructure to a global audience.

Bulk Industrial Real Estate maintains a landbank of strategic locations for industrial real estate projects in Norway, Sweden and Denmark. Based on standard designs, we develop, build and operate warehouse buildings, cross dock terminals and other industrial facilities.

Bulk Data Centers delivers strategically located Nordic data centers and a dedication to service excellence that enable customers to reduce costs and environmental impact with ultra-flexible, highly connected and scalable solutions. 

Bulk Fiber Networks connects the Nordics with the world’s major markets via low-latency and high-capacity fiber networks. We build and operate international and intra-Nordic fiber infrastructure that is designed to meet the large-scale data transport needs of the future.

About BentallGreenOak

BentallGreenOak is a leading, global real estate investment management advisor and a globally recognized provider of real estate services. BentallGreenOak serves the interests of more than 750 institutional clients with approximately $50 billion USD of assets under management (as of September 30, 2020) and expertise in the asset management of office, logistics, multi-residential and retail property across the globe. BentallGreenOak has offices in 24 cities across twelve countries with deep, local knowledge, experience, and extensive networks in the regions where we invest and manage real estate assets on behalf of our clients.

In Europe, BentallGreenOak is a leading investment manager with over 50 professionals and $5.2 billion USD in AUM across debt and equity, with strategies spanning from Core to Value-Add and Development, with its own internalised operating capability. The firm has acquired or developed over 133 logistics assets comprising 4.8 million square meters (52 million square feet) since 2015. BentallGreenOak’s investment vehicles have assembled a large and diversified land bank across Europe, currently owning or controlling 4.4 million square meters of land (capable of building 2.2 million square meters of space) zoned for Logistics, Data Centers and Cold Storage.

BentallGreenOak is a part of SLC Management, which is the institutional alternatives and traditional asset management business of Sun Life.

The assets under management shown above include real estate equity and mortgage investments managed by the BentallGreenOak group of companies and their affiliates.

For more information, please visit www.bentallgreenoak.com

About Geveran

Geveran Trading Co. Limited ("Geveran"), a company indirectly controlled by trusts established by Mr John Fredriksen for the benefit of his immediate family, invested in Bulk Infrastructure in 2018 and currently has an ownership stake of approximately 14%.

About Bulk Industrier

Bulk Industrier AS is an industrial investment company of Norwegian entrepreneur Peder Nærbø (Naerboe). The company focus on investments that create sustainable solutions with scalable impact. Bulk Industrier is the controlling shareholder to Bulk Infrastructure AS where Mr Naerboe conducts his active leadership as a business and industry developer.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye